Olanzapina Eg Stada (Olanzapine)

Olanzapine, the active ingredient in Olanzapina Eg Stada, is an atypical antipsychotic presented as a tablet for oral use. It is used to manage symptoms of schizophrenia and bipolar disorder in adults. GNH USA supplies Olanzapina Eg Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olanzapina Eg Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olanzapine is indicated for disorders that involve dopamine and serotonin dysregulation, primarily within the psychotic and mood disorder spectrum.

- Schizophrenia: helps reduce hallucinations, delusions and thought disorder. - Bipolar I disorder (manic episodes): assists in controlling elevated mood, agitation and rapid speech. - Maintenance therapy for bipolar disorder: helps sustain mood stability and prevent relapse. - Adjunctive treatment in major depressive disorder with psychotic features: may be used alongside antidepressants to address psychotic symptoms. - Treatment of acute agitation in schizophrenia: provides rapid calming effects in emergency settings.

Olanzapine may cause a range of adverse reactions, from mild to potentially serious.

Common Side Effects: - Weight gain: increased appetite and caloric intake. - Sedation: drowsiness or feeling of fatigue. - Dry mouth: reduced salivation. - Constipation: slowed gastrointestinal motility. - Elevated blood glucose: hyperglycaemia risk. - Dyslipidaemia: increased cholesterol and triglycerides.

Serious or Rare Side Effects: - Neuroleptic malignant syndrome: high fever, muscle rigidity, autonomic instability. - Tardive dyskinesia: involuntary, repetitive movements. - Severe hypotension: marked drop in blood pressure. - Agranulocytosis: dangerously low white‑blood cell count. - Seizures: occurrence of convulsive episodes. - Hepatic dysfunction: elevated liver enzymes or liver injury.

Olanzapine should be used with careful clinical monitoring and patient education.

- Metabolic monitoring: regularly assess weight, fasting glucose, and lipid profile. - Cardiovascular assessment: monitor blood pressure and heart rate  . - CNS  :  C        - Diabetes   tt   t   d   ewline -   ewline   ewline   ewline  ewline  

t  ewline  ewline      ewline  \

The            t    ewline  ....